Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5529
0.004900.89%
At close: -
$0.5411
-0.01-2.13%
After Hours: Mar 24, 7:30 PM EDT
Comments
Loading...
VolitionRX Analyst Ratings and Price Targets | AMEX:VNRX | Benzinga
VolitionRX Ltd has a consensus price target of $4.72 based on the ratings of 10 analysts. The high is $6 issued by EF Hutton on June 1, 2023. The low is $2 issued by Cantor Fitzgerald on August 16, 2023. The 3 most-recent analyst ratings were released by D. Boral Capital on March 20, 2025, March 13, 2025, and March 12, 2025, respectively. With an average price target of $5 between D. Boral Capital, there's an implied 824.04% upside for VolitionRX Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
EF Hutton
EF Hutton
Cantor Fitzgerald
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for VolitionRX
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 03/13/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 03/12/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | — | Benchmark | Bruce Jackson42% | — | Reiterates | → Hold | Get Alert |
| 11/15/2024 | Buy Now | 824.04% | D. Boral Capital | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 824.04% | EF Hutton | Jason Kolbert48% | $5 → $5 | Maintains | Buy | Get Alert |
| 08/26/2024 | Buy Now | 824.04% | EF Hutton | Tim Moore58% | → $5 | Assumes | Buy → Buy | Get Alert |
| 08/16/2024 | Buy Now | — | Benchmark | Bruce Jackson42% | — | Reiterates | → Hold | Get Alert |
| 06/07/2024 | Buy Now | 639.23% | EF Hutton | Tim Moore58% | $4 → $4 | Maintains | Buy | Get Alert |
| 05/16/2024 | Buy Now | 362.02% | Cantor Fitzgerald | Ross Osborn51% | $2.5 → $2.5 | Reiterates | Overweight → Overweight | Get Alert |
| 05/14/2024 | Buy Now | 731.64% | EF Hutton | Tim Moore58% | $4.5 → $4.5 | Maintains | Buy | Get Alert |
| 03/27/2024 | Buy Now | 362.02% | Cantor Fitzgerald | Ross Osborn51% | $2.5 → $2.5 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | Buy Now | 731.64% | EF Hutton | Tim Moore58% | $4.5 → $4.5 | Maintains | Buy | Get Alert |
| 01/02/2024 | Buy Now | 731.64% | EF Hutton | Tim Moore58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2023 | Buy Now | 731.64% | EF Hutton | Tim Moore58% | → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 11/16/2023 | Buy Now | 362.02% | Cantor Fitzgerald | Ross Osborn51% | $2.1 → $2.5 | Maintains | Overweight | Get Alert |
| 10/30/2023 | Buy Now | 731.64% | EF Hutton | Tim Moore58% | → $4.5 | Initiates | → Buy | Get Alert |
| 08/16/2023 | Buy Now | 269.62% | Cantor Fitzgerald | Kyle Mikson34% | $3 → $2 | Maintains | Overweight | Get Alert |
| 06/01/2023 | Buy Now | 1008.85% | EF Hutton | Tony Butler43% | → $6 | Assumes | → Buy | Get Alert |
| 03/16/2023 | Buy Now | 1008.85% | EF Hutton | Constantine Davides37% | → $6 | Reiterates | → Buy | Get Alert |
| 02/01/2023 | Buy Now | — | Benchmark | Bruce Jackson42% | — | Downgrade | Buy → Hold | Get Alert |
| 12/19/2022 | Buy Now | 1008.85% | EF Hutton | Constantine Davides37% | → $6 | Initiates | → Buy | Get Alert |
| 08/23/2022 | Buy Now | 824.04% | Maxim Group | Jason McCarthy42% | $8 → $5 | Maintains | Buy | Get Alert |
| 08/15/2022 | Buy Now | 1008.85% | Aegis Capital | Nathan Weinstein31% | $9 → $6 | Maintains | Buy | Get Alert |
FAQ
What is the target price for VolitionRX (VNRX) stock?
The latest price target for VolitionRX (AMEX:VNRX) was reported by D. Boral Capital on March 20, 2025. The analyst firm set a price target for $5.00 expecting VNRX to rise to within 12 months (a possible 824.04% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX:VNRX) was provided by D. Boral Capital, and VolitionRX maintained their buy rating.
When was the last upgrade for VolitionRX (VNRX)?
There is no last upgrade for VolitionRX
When was the last downgrade for VolitionRX (VNRX)?
The last downgrade for VolitionRX Ltd happened on February 1, 2023 when Benchmark changed their price target from N/A to N/A for VolitionRX Ltd.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a maintained with a price target of $5.00 to $5.00. The current price VolitionRX (VNRX) is trading at is $0.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.